U.S. Entertainment Stock News

NYSE:WSM
NYSE:WSMSpecialty Retail

Williams Sonoma’s GreenRow Adds Naturepedic To Support Organic Sleep Valuation Narrative

Naturepedic has entered an exclusive retail partnership with GreenRow, a Williams-Sonoma (NYSE:WSM) brand. The collaboration introduces a dedicated assortment of certified organic sleep products for GreenRow customers. The new Aurora Mattress is debuting as part of the deal, expanding Naturepedic's organic mattress lineup. For Williams-Sonoma, known for premium home and kitchen brands, this move adds more certified organic, healthier sleep options to the GreenRow offering. It aligns with...
NYSE:DOCN
NYSE:DOCNIT

Is It Time To Reconsider DigitalOcean (DOCN) After Recent Share Price Volatility

If you are wondering whether DigitalOcean Holdings is still attractively priced after its recent run, you are not alone. This article will help you weigh what the current share price really reflects. The stock most recently closed at US$56.06, with returns of 1.5% over the last 30 days, 14.5% year to date, and 30.8% over the past year. The last 7 days showed an 11.9% decline that may have changed how some investors see the risk and reward trade off. Recent news coverage has focused on...
NYSE:GPOR
NYSE:GPOROil and Gas

A Look At Gulfport Energy (GPOR) Valuation After Earnings Turnaround And Expanded Buybacks

Gulfport Energy (GPOR) just posted fourth quarter and full year 2025 results, reporting a move from prior losses to profit along with higher revenue, and also provided updated production guidance and an expanded share repurchase plan. See our latest analysis for Gulfport Energy. At a share price of US$208.66, Gulfport Energy has seen a 3.30% 1 day share price return and a 2.20% 30 day share price return, but a 5.92% 90 day share price decline. The 1 year total shareholder return of 22.89% and...
NYSE:BVN
NYSE:BVNMetals and Mining

Buenaventura Dividend Policy Rises As San Gabriel Nears Full Contribution

Buenaventura (NYSE:BVN) has approved a higher dividend payout policy, supported by strong operating cash flow. The Board also cleared a higher dividend distribution to shareholders under the new framework. The San Gabriel project is approaching completion, with ramp up reported as close to finished. For you as an investor, the combination of a higher dividend payout policy and a near complete San Gabriel ramp up is a key development for Compañía de Minas Buenaventura, a precious metals...
NYSE:OGE
NYSE:OGEElectric Utilities

Is It Too Late To Consider OGE Energy (OGE) After Its Strong Multi‑Year Share Price Run?

If you are wondering whether OGE Energy is still fairly priced after its recent run, or if the current share price is giving you a margin of safety, this article walks through what the numbers say about value. With the stock at US$49.14 and returns of 3.8% over 7 days, 12.5% over 30 days, 14.6% year to date, 10.3% over 1 year, 56.3% over 3 years and 93.0% over 5 years, many investors are asking whether the current price still makes sense. Recent attention on OGE Energy has focused on how a...
NasdaqGS:LZ
NasdaqGS:LZProfessional Services

Reassessing LegalZoom (LZ) After A 31% One‑Year Share Price Decline

If you are wondering whether LegalZoom.com’s current share price reflects its true worth, you are not alone. This article focuses on what the numbers say about value. The stock last closed at US$7.03, with a 7 day return of 7.2%, but declines of 20.9% over 30 days, 26.7% year to date, and 30.8% over the past year. These moves have put valuation questions front and center for many investors, who are weighing short term swings against the longer term picture. Evergreen coverage like this aims...
NasdaqGS:PTCT
NasdaqGS:PTCTBiotechs

Assessing PTC Therapeutics (PTCT) Valuation After Contrasting Quarterly Loss And Full Year Profit Turnaround

PTC Therapeutics (PTCT) shares are in focus after the company released fourth quarter and full year 2025 results, which combined weaker quarterly figures with a sharp full year swing to positive earnings. See our latest analysis for PTC Therapeutics. At a share price of US$68.19, PTC Therapeutics has recently seen weaker short term share price returns, with a 30 day share price return of 9.72% and a year to date share price return of 11.14%. Its 1 year total shareholder return of 23.4% and 3...
NasdaqGS:FULT
NasdaqGS:FULTBanks

A Look At Fulton Financial (FULT) Valuation After Recent Share Price Pullback

Fulton Financial (FULT) is back on investor radars after a recent share pullback, with the stock closing at US$20.45. That is shifting sentiment toward its valuation and the bank’s underlying financial profile. See our latest analysis for Fulton Financial. The recent 5.5% one day share price decline and 8.7% 7 day share price return dip sit against a 90 day share price return of 11.2% and 1 year total shareholder return of 7.3%. This suggests that longer term momentum is still intact despite...
NYSE:BKU
NYSE:BKUBanks

Is Slowing Net Interest Income Forcing BankUnited (BKU) To Rethink Its Expansion Ambitions?

In recent months, BankUnited reported solid quarterly results and continued investments in digital capabilities and new markets, even as its net interest income growth trailed the broader banking industry and analysts projected a weaker efficiency ratio ahead. This tension between operational expansion and concerns about slowing profitability has led some analysts to question how durable BankUnited’s current growth ambitions may be. Next, we’ll examine how these concerns about slowing net...
NYSE:DELL
NYSE:DELLTech

Dell’s Record AI Results And Capital Returns Tested Against Valuation Upside

Dell Technologies (NYSE:DELL) reported record financial results, supported by a $43b AI server backlog. The company set ambitious AI growth targets and announced a $10b increase to its share repurchase authorization. Dell raised its dividend by 20% and introduced the rugged, liquid cooled PowerEdge XR9700 server for edge AI workloads. The company expanded partnerships, including a deeper alliance with Unisys and an extended collaboration with McLaren Racing in Formula 1. For investors...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

Amneal Q4 2025 Highlights Shift Toward Higher Value Pharma Segments

Amneal Pharmaceuticals (NasdaqGS:AMRX) reported strong Q4 2025 results, highlighting progress across specialty, injectables, biosimilars, and complex generics. The company announced multiple product launches and regulatory approvals, expanding its presence in higher value segments. Management highlighted a promising pipeline, including biosimilars expected to enter the US market. Amneal also emphasized its collaboration with Pfizer on GLP-1 therapies as a key focus area for future...
NYSE:HD
NYSE:HDSpecialty Retail

Is Home Depot (HD) Still Attractively Priced After Housing Bellwether Spotlight?

If you are wondering whether Home Depot at around US$380 is still a solid entry or starting to look expensive, you are not alone. The stock last closed at US$380.72, with returns of 1.6% over 30 days, 10.1% year to date and 69.6% over 5 years, while the 1 year return is a 1.6% decline and the 3 year return is 37.7%. Recent news coverage has focused on Home Depot's role as a bellwether for US housing and renovation trends, and what that might mean for longer term demand. At the same time,...
NasdaqGS:CAI
NasdaqGS:CAIBiotechs

Caris Life Sciences Advances Early Detection And AI Tools As Valuation Lags

Caris Life Sciences (NasdaqGS:CAI) reported an interim readout from its Achieve 1 study for the Caris Detect multi cancer early detection blood test. The interim data show sensitivity and specificity that the company says outperform current methylation based approaches. Caris is adding Whole Transcriptome Sequencing to Caris Detect to deepen molecular resolution in the test. The company also introduced a new AI powered breast cancer signature in its Molecular Tumor Board Report to expand...
NYSE:HG
NYSE:HGInsurance

Hamilton Insurance Group’s Valuation After Robust Earnings And A Sizable Special Dividend

Hamilton Insurance Group (HG) is back on investors’ radar after reporting fourth quarter and full year 2025 results, declaring a special dividend of $2.00 per share and attracting renewed attention from Wall Street research desks. See our latest analysis for Hamilton Insurance Group. At a share price of $31.59, Hamilton Insurance Group has seen a 30 day share price return of 13.84% and a year to date share price return of 15.84%. The 1 year total shareholder return of 61.50% points to strong...
NYSE:EPR
NYSE:EPRSpecialized REITs

Stronger 2025 Earnings, Higher Dividend and New CIO Could Be A Game Changer For EPR Properties (EPR)

EPR Properties recently reported its fourth-quarter and full-year 2025 results, showing higher revenue of US$182.95 million for the quarter and US$718.36 million for the year, a swing to quarterly net income of US$66.9 million, and announced a 5.1% increase in its annualized common dividend to US$3.72 per share alongside updated 2026 earnings guidance. The company also continued reshaping its business with additional experiential real estate acquisitions, new debt and equity financing...
NasdaqCM:ONCY
NasdaqCM:ONCYBiotechs

Oncolytics Biotech Refocuses On Rare Cancers After GOBLET Enrollment Milestone

Oncolytics Biotech (NasdaqCM:ONCY) has completed patient enrollment in its Phase 1/2 GOBLET study. The company is moving ahead with pivotal trials in squamous cell anal cancer and metastatic colorectal cancer. Management is shifting clinical focus and resources toward these rare cancer indications and planning FDA interactions related to potential approval pathways. Oncolytics Biotech focuses on cancer therapies, and the GOBLET study sits at the center of that effort. With enrollment now...
NasdaqGS:SNPS
NasdaqGS:SNPSSoftware

Reassessing Synopsys (SNPS) After Recent Pullback And NVIDIA’s US$2.0b Investment

If you are wondering whether Synopsys at around US$414 a share still makes sense for your portfolio, starting with a clear view of what you are paying for is essential. The stock is currently below recent levels, with a 5.9% decline over the last 7 days, 11.0% over 30 days, a 13.8% decline year to date and a 9.5% decline over 1 year, while the 3 year and 5 year returns sit at 12.7% and 81.7% respectively. These moves have put valuation back in focus for many investors, especially given...
NasdaqGS:DAKT
NasdaqGS:DAKTElectronic

Daktronics OCVIBE Deal And Leadership Shift Test Rich Valuation Story

Daktronics (NasdaqGS:DAKT) has agreed to supply an integrated digital display system across the OCVIBE campus, a large mixed-use development project. The company also announced an executive leadership change, with the former Interim President and CEO moving into an advisory role. Both updates relate to Daktronics' positioning in large commercial installations and its ongoing leadership structure. Daktronics focuses on electronic scoreboards, digital signage, and large-format LED video...
NasdaqGS:SEIC
NasdaqGS:SEICCapital Markets

What SEI Investments (SEIC)'s Litigation Finance Tie-Up and Solid Quarter Means For Shareholders

In late February 2026, Pravati Capital announced a partnership with SEI Investments' SEI Access™ marketplace to make litigation finance available as an alternative investment option for registered investment advisors and financial professionals through an end-to-end platform. Around the same time, SEI reported quarterly revenue of US$607.9 million, up 9.1% year on year and slightly above analyst expectations, with management highlighting disciplined execution and broad-based strength across...
NYSE:PBI
NYSE:PBICommercial Services

Pitney Bowes Profit Rebound, Capital Moves Might Change The Case For Investing In Pitney Bowes (PBI)

Pitney Bowes recently reported past fourth-quarter and full-year 2025 results showing higher profitability despite lower revenue, while also affirming a US$0.09 quarterly dividend and completing a share buyback of 37,039,845 shares for US$390.77 million. Alongside these actions, the company filed a mixed shelf registration and launched a US$200 million 7.250% senior unsecured notes due 2029 offering, highlighting an active approach to balance sheet and capital planning. We’ll now examine how...
NYSE:RS
NYSE:RSMetals and Mining

Reliance Dividend Hike And Buybacks Shape Future Payout Sustainability

Reliance, Inc. (NYSE:RS) raised its quarterly dividend. The company is continuing its long term share buyback program. Both actions reflect management’s current approach to capital allocation and shareholder distributions. Reliance, Inc. (NYSE:RS) operates in the metals service center space, supplying processed metal products to a wide range of end markets. In that kind of business, decisions around dividends and buybacks can matter as much to investors as day to day price moves for steel...
NYSE:HLT
NYSE:HLTHospitality

A Look At Hilton Worldwide Holdings (HLT) Valuation As It Defies Hotel Industry Margin Pressures

Hilton Worldwide Holdings (HLT) is drawing attention after standing out in a hotel sector facing margin pressure, as investors weigh its resilient demand, net unit growth, RevPAR trends, and expanding international footprint. See our latest analysis for Hilton Worldwide Holdings. At a share price of US$311.78, Hilton’s recent pullback, with a 1-day share price return decline of 1.90% and a 7-day share price return decline of 1.32%, contrasts with its 30-day and 90-day share price returns of...
NasdaqGS:VEON
NasdaqGS:VEONWireless Telecom

VEON And Hala Ride Hailing Push Tests Digital Services Profit Potential

VEON and ride hailing operator Hala have signed a Memorandum of Understanding to expand mobility services in frontier markets. The partnership aims to combine Hala's ride hailing capabilities with VEON's digital platforms and local presence. The agreement builds on VEON's existing mobility offerings and Hala's scale in Dubai to broaden VEON's digital ecosystem beyond telecom. NasdaqGS:VEON currently trades at $55.89, with a return of 24.9% over the past year and a very large gain over three...
NYSE:SAM
NYSE:SAMBeverage

A Look At Boston Beer Company (SAM) Valuation After 2026 Guidance And Margin-Focused Update

Boston Beer Company (SAM) has given investors fresh 2026 earnings guidance after releasing its 2025 results, pairing lower volumes and sales with gross margin gains, cost efficiencies, and ongoing share repurchases. See our latest analysis for Boston Beer Company. The 90 day share price return of 15.28% and 30 day gain of 6.16% suggest improving momentum into the latest results. However, the 1 year total shareholder return of a 6.97% decline and 5 year total shareholder return of a 79.16%...